Agilent Technologies, Inc.

New York Stock Exchange
Back to all articles
Slightly Bullish +25

Agilent Technologies (NYSE:A) Downgraded by Wall Street Zen to Hold

📉 Wall Street Zen downgraded Agilent Technologies from 'buy' to 'hold' in a note issued on Saturday.

📊 The company reported Q2 earnings of $1.49 per share, beating the consensus estimate of $1.41 by $0.08.

💰 Revenue reached $1.83 billion for the quarter, surpassing analyst expectations of $1.80 billion.

📈 Year-over-year revenue growth was 10.0%, driven by performance in life sciences and diagnostics markets.

🎯 Agilent set FY 2026 EPS guidance between $6.00 and $6.10, aligning closely with analyst expectations of $6.01.

🏦 The stock trades at an average analyst target price of $159.35 based on data from MarketBeat.

📉 Analyst consensus includes 2 Strong Buy ratings, 13 Buy ratings, and 4 Hold ratings for the stock.

🔍 Piper Sandler initiated coverage with a 'neutral' rating and a $150.00 price target in June.

🔍 Jefferies Financial Group initiated coverage with a 'hold' rating and a $135.00 price target in July.

💼 Barclays upgraded its rating to 'overweight' and raised the price objective from $145.00 to $150.00.

📈 TD Cowen increased its target price to $155.00 and maintained a 'buy' rating in May.

🏢 Institutional investors including SHP Wealth Management and Core Wealth Advisors opened new positions in Q4.

Bullish Signals
  • Agilent Technologies beat earnings expectations with $1.49 EPS compared to the consensus of $1.41, demonstrating strong operational execution.
  • Revenue of $1.83 billion exceeded analyst estimates of $1.80 billion, indicating robust demand for scientific instrumentation.
  • The company achieved a net margin of 19.55% and a return on equity of 24.33%, reflecting healthy profitability and capital efficiency.
  • Revenue grew by 10.0% year-over-year, showing sustained top-line expansion in the life sciences sector.
  • FY 2026 EPS guidance of $6.00-$6.10 aligns with analyst consensus of $6.01, suggesting confidence in future performance.
  • Multiple analysts have maintained 'buy' or 'overweight' ratings, including TD Cowen and Barclays, supporting the stock's bullish case.
Risk Factors
  • Wall Street Zen downgraded the stock from 'buy' to 'hold', signaling potential concerns about valuation or growth sustainability.
  • Piper Sandler initiated coverage with a 'neutral' rating, indicating a lack of immediate upside catalysts in their view.
  • Jefferies Financial Group set a lower price target of $135.00 compared to the broader analyst consensus of $159.35.
Full Analysis
Agilent Technologies (NYSE:A) received a downgrade from 'buy' to 'hold' by Wall Street Zen, though the stock maintains an average analyst rating of 'Moderate Buy' with a target price of $159.35. While Wall Street Zen initiated coverage recently, other major firms like Piper Sandler and Jefferies hold neutral or hold ratings with targets ranging from $135 to $150, contrasting with bullish positions from TD Cowen and Barclays. The company reported strong quarterly results ending May 27th, beating consensus estimates with earnings per share of $1.49 versus the expected $1.41 and revenue of $1.83 billion against a forecast of $1.80 billion. Key financial metrics included a net margin of 19.55%, a return on equity of 24.33%, and year-over-year revenue growth of 10.0%. Agilent provided forward guidance for fiscal year 2026 EPS between $6.00 and $6.10, with Q3 2026 expected to range from $1.48 to $1.50. Institutional investors have been active in the fourth quarter, with several wealth management firms establishing new positions valued between $26,000 and $31,000. As a global provider of scientific instrumentation for life sciences and diagnostics, Agilent continues to focus on analytical instruments and laboratory services following its 1999 spin-off from Hewlett-Packard. The recent analyst activity reflects mixed sentiment regarding the stock's valuation despite solid operational performance.